REQUEST A DEMO
Total
USD $0.00
Search more companies

Arven Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Arven Ilac A.S. is based in Turkiye, with the head office in Istanbul. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on November 28, 2012. 427 (2024) employees currently work for Arven Ilac A.S.. In 2021, the company reported a net sales revenue drop of 18.93%. During that time, Arven Ilac A.S.’s total assets decreased by 6.17%. The net profit margin of Arven Ilac A.S. decreased by 0.38% in 2021.

Headquarters
No:14 Balabandere Caddesi Ilac Sanayi Sokak Sariyer
Istanbul; Marmara; Postal Code: 34457

Contact Details: Purchase the Arven Ilac A.S. report to view the information.

Website: http://www.arvenilac.com.tr

Basic Information
Total Employees:
Purchase the Arven Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Arven Ilac A.S. report to view the information.
Incorporation Date:
November 28, 2012
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Arven Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-18.93%
Total operating revenue
-18.93%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
16.51%
Total assets
-6.17%
Total equity
-24.09%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.38%
Return on Equity (ROE)
-2.9%
Quick Ratio
0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?